When Matter Builds Itself: Blueprints from Life to Materials
Nano Letters · 15.04.2026 · 26 (14) · 4531-4538
DOI: 10.1021/acs.nanolett.6c00057 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nano Letters, online erschienen am 02.04.2026. Verfasst von L Aloisio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Organic Electronics, Department of Science and Technology, Linköping University, SE-60174 Norrköping, Sweden. Hauptthemen laut MEDLINE: Nanostructures. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Universit? e della Ricerca, RAISE (Robotics and AI for Socio-economic Empowerment)? ? NextGeneration EU PNRR MUR - M4C2.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Organic Electronics, Department of Science and Technology, Linköping University, SE-60174 Norrköping, Sweden.
- Center for Nanoscience and Technology, Istituto Italiano di Tecnologia, Via Rubattino 81, 20134 Milan, Italy.
- Department of Physics, Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milan, Italy.
ORCID-Profile: G Lanzani
Förderung
- Ministero dell'Universit? e della Ricerca
- RAISE (Robotics and AI for Socio-economic Empowerment)? ? NextGeneration EU PNRR MUR - M4C2
Zitieren
APA
Aloisio, L., Marangi, F., & Lanzani, G. (2026). When Matter Builds Itself: Blueprints from Life to Materials. Nano Letters, 26(14), 4531-4538. https://doi.org/10.1021/acs.nanolett.6c00057
Vancouver
Aloisio L, Marangi F, Lanzani G. When Matter Builds Itself: Blueprints from Life to Materials. Nano Letters. 2026;26(14):4531-4538. doi:10.1021/acs.nanolett.6c00057
BibTeX
@article{Aloisio2026,
author = {Aloisio, L and Marangi, F and Lanzani, G},
title = {When Matter Builds Itself: Blueprints from Life to Materials},
journal = {Nano Letters},
year = {2026},
volume = {26},
number = {14},
pages = {4531--4538},
doi = {10.1021/acs.nanolett.6c00057}
}
EUVIMED